• Molecular NameCefpiramide
  • SynonymSM-1652
  • Weight612.648
  • Drugbank_IDDB00430
  • ACS_NO70797-11-4
  • Show 3D model
  • LogP (experiment)-0.294
  • LogP (predicted, AB/LogP v2.0)0.11
  • pkaN/A
  • LogD (pH=7, predicted)-3.81
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.19
  • LogSw (predicted, AB/LogsW2.0)6.35
  • Sw (mg/ml) (predicted, ACD/Labs)0.2
  • No.of HBond Donors5
  • No.of HBond Acceptors15
  • No.of Rotatable Bonds9
  • TPSA263.36
  • StatusFDA approved
  • AdministrationIntravenous, intramuscular
  • PharmacologyA third-generation cephalosporin antibiotic.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding96.2
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life4.44 h
  • ExcretionRenal and fecal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAdverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A